Conversely, increased levels of HLA-DR expression on CD14+ CD16− monocytes, HLA-DR on CD14+ CD16+ monocytes, and the percentage of Naive CD4+ T cells were found to correlate with a higher risk of BC. This evidence concerns the gene CD4 and breast cancer.